Risk Factors for De Novo Overactive Bladder After Midurethral Sling

Tasha Serna-Gallegos,Sonia Dutta,Carly Crowder,Paul Wadensweiler,Emily L. Whitcomb,Noelani M. Guaderrama
DOI: https://doi.org/10.1097/01.ogx.0001016684.05069.42
2024-04-25
Obstetrical & Gynecological Survey
Abstract:(Abstracted from Urogynecology 2024;30:59–64 The standard surgical treatment for stress urinary incontinence is midurethral sling (MUS) placement, due to its excellent efficacy, minimally invasive approach, and low overall rates of complication. However, development of de novo overactive bladder (OAB) symptoms is a known complication of anti-incontinence procedures and previously described as occurring in 5%–32% after fascial sling or Burch urethropexy.
obstetrics & gynecology
What problem does this paper attempt to address?